H.R. 2325 — Introduced in House

I 114th CONGRESS 1st Session H. R. 2325 IN THE HOUSE OF REPRESENTATIVES May 14, 2015 Mrs. Brooks of Indiana (for herself and Mr. Bilirakis) introduced the following bill; which was referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend title XVIII of the Social Security Act to provide for a pharmaceutical and technology ombudsman under the Medicare program. 1. Medicare pharmaceutical and technology ombudsman Section 1808(c) of the Social Security Act (42 U.S.C. 1395b–9(c)) is amended by adding at the end the following new paragraph: (4) Pharmaceutical and technology ombudsman Not later than 12 months after the date of the enactment of this paragraph, the Secretary shall provide for a pharmaceutical and technology ombudsman within the Centers for Medicare & Medicaid Services who shall receive and respond to complaints, grievances, and requests that— (A) are from entities that manufacture pharmaceutical, biotechnology, medical device, or diagnostic products that are covered or for which coverage is being sought under this title; and (B) regard coverage, coding, or payment under this title for such products. .